Research Topics
Species | P PicciniSummaryAffiliation: National Institute for Medical Research Country: UK Publications
| Collaborators
|
Detail Information
Publications
Endogenous dopamine release after pharmacological challenges in Parkinson's diseasePaola Piccini
MRC Clinical Sciences Centre and Division of Neuroscience, Faculty of Medicine, Imperial College, Hammersmith Hospital, London, United Kingdom
Ann Neurol 53:647-53. 2003..Our data also show that the capacity to release normal DA levels in prefrontal areas after a pharmacological challenge is preserved in severe stages of the disease...
Dopamine transporter: basic aspects and neuroimagingPaola P Piccini
MRC Clinical Sciences Centre, and Division of Neuroscience, Faculty of Medicine, Imperial College, Hammersmith Hospital, London, United Kingdom
Mov Disord 18:S3-8. 2003....
Functional brain imaging in the differential diagnosis of Parkinson's diseasePaola Piccini
MRC Clinical Sciences Centre and Division of Neuroscience, Faculty of Medicine, Imperial College, Hammersmith Hospital, London, UK
Lancet Neurol 3:284-90. 2004..Functional neuroimaging holds the promise of improved diagnosis and allows assessment in early disease. In this review, the use of PET and single photon emission CT in the differential diagnosis of IPD are discussed...
Neurodegenerative movement disorders: the contribution of functional imagingPaola Piccini
MRC Clinical Sciences Centre and Division of Neuroscience, Faculty of Medicine, Imperial College, Hammersmith Hospital, London, UK
Curr Opin Neurol 17:459-66. 2004..This review discusses recent findings in this field, with a focus on the detection and characterization of receptor binding and presynaptic dopamine changes in movement disorders...
New developments of brain imaging for Parkinson's disease and related disordersPaola Piccini
MRC Clinical Sciences Centre and Division of Neuroscience and Mental Health, Imperial College, Hammersmith Hospital, London, United Kingdom
Mov Disord 21:2035-41. 2006..This review focuses on these recent advances in neuroimaging technology and their use for the diagnosis and assessment of PD and other parkinsonian disorders...
Familial progressive supranuclear palsy: detection of subclinical cases using 18F-dopa and 18fluorodeoxyglucose positron emission tomographyP Piccini
MRC Clinical Science Center, Imperial College School of Medicine, Hammersmith Hospital, DuCane Road, W12 ONN London, England
Arch Neurol 58:1846-51. 2001..The rarity of reports of familial PSP may be attributed in part to an inability to detect subclinical disease in affected relatives who subsequently die before symptoms clinically develop...
The catechol-O-methyltransferase (COMT) inhibitor entacapone enhances the pharmacokinetic and clinical response to Sinemet CR in Parkinson's diseaseP Piccini
Department of Neurology, Imperial College, School of Medicine, Hammersmith Hospital, London, UK
J Neurol Neurosurg Psychiatry 68:589-94. 2000....
Dyskinesias after transplantation in Parkinson's diseasePaola Piccini
PET Neurology Group, MRC Clinical Sciences Centre and Division of Neurosciences, Imperial College of Science, Technology and Medicine, Hammersmith Hospital Campus, Du Cane Road, London W12 ONN, UK
Lancet Neurol 1:472. 2002
Dopamine release from nigral transplants visualized in vivo in a Parkinson's patientP Piccini
MRC Cyclotron Unit, Imperial College School of Medicine, Hammersmith Hospital, Du Cane Road, London W12 0NN, UK
Nat Neurosci 2:1137-40. 1999..Despite an ongoing disease process, grafted neurons can thus continue for a decade to store and release dopamine and give rise to substantial symptomatic relief...
Long-term clinical and positron emission tomography outcome of fetal striatal transplantation in Huntington's diseaseI Reuter
Academic Department of Neuroscience, Kings College Hospital, London, UK
J Neurol Neurosurg Psychiatry 79:948-51. 2008..The other patient did not improve clinically or radiologically. Our results indicate that striatal transplantation in HD may be beneficial but further studies are needed to confirm this...
Clinical correlates of levodopa-induced dopamine release in Parkinson disease: a PET studyN Pavese
MRC Clinical Sciences Centre and Division of Neurosciences, Faculty of Medicine, Imperial College, Hammersmith Hospital, Du Cane Road, London W12 ONN, UK
Neurology 67:1612-7. 2006..In contrast, relief of parkinsonian tremor and axial symptoms is not related to striatal synaptic dopamine levels and presumably occurs via extrastriatal mechanisms...
Characterization of dopaminergic dysfunction in familial progressive supranuclear palsy: an 18F-dopa PET studyY F Tai
MRC Clinical Sciences Centre and Division of Neurosciences, Hammersmith Hospital, Imperial College London, United Kingdom
J Neural Transm 114:337-40. 2007..This is the first in vivo documentation of cortical dopaminergic deficiency in PSP. Reduced striatal (18)F-dopa uptake in susceptible relatives may predict later clinical disease...
Factors affecting the clinical outcome after neural transplantation in Parkinson's diseasePaola Piccini
MRC Clinical Sciences Centre and Division of Neuroscience, Faculty of Medicine, Imperial College, Hammersmith Hospital, London, UK
Brain 128:2977-86. 2005..Finally, our data provide evidence that long-term immunosuppression can be withdrawn without interfering with graft survival or the motor recovery induced by transplantation...
Microglial activation in presymptomatic Huntington's disease gene carriersYen F Tai
MRC Clinical Sciences Centre, Imperial College London, Hammersmith Hospital, Du Cane Road, London W12 0NN, UK
Brain 130:1759-66. 2007..PK PET may be a useful marker of active subclinical disease and a means of investigating the efficacy of neuroprotection strategies in PGCs...
Microglial activation correlates with severity in Huntington disease: a clinical and PET studyN Pavese
MRC Clinical Sciences Centre and Division of Neuroscience, Faculty of Medicine, Imperial College, Hammersmith Hospital, London, UK
Neurology 66:1638-43. 2006....
Progressive striatal and cortical dopamine receptor dysfunction in Huntington's disease: a PET studyNicola Pavese
MRC Clinical Sciences Centre and Division of Neuroscience, Faculty of Medicine, Imperial College, Hammersmith Hospital, London, UK
Brain 126:1127-35. 2003..This probably reflects both contributions from other affected brain structures and high variance in these measures...
Hypothalamic involvement in Huntington's disease: an in vivo PET studyMarios Politis
Division of Clinical Neurosciences and MRC Clinical Sciences Centre, Faculty of Medicine, Hammersmith Hospital, Imperial College London, London, UK
Brain 131:2860-9. 2008....
Dopaminergic dysfunction in unrelated, asymptomatic carriers of a single parkin mutationN L Khan
MRC Clinical Sciences Centre, and Division of Neuroscience, Faculty of Medicine, Imperial College, Hammersmith Hospital, London, UK
Neurology 64:134-6. 2005..Four had subtle extrapyramidal signs. Parkin heterozygosity is a risk factor for nigrostriatal dysfunction and in some may contribute to late-onset Parkinson disease...
Depressive symptoms in PD correlate with higher 5-HTT binding in raphe and limbic structuresM Politis
MRC Clinical Sciences Centre and Centre for Neuroscience, Faculty of Medicine, Imperial CollegeLondon, UK
Neurology 75:1920-7. 2010..Depression associated with Parkinson disease (PD) has a different symptom profile to endogenous depression. The etiology of depression in PD remains uncertain though abnormal serotonergic neurotransmission could play a role...
Dopamine release during sequential finger movements in health and Parkinson's disease: a PET studyInes K Goerendt
MRC Clinical Sciences Centre and Division of Neuroscience, Faculty of Medicine, Imperial College, Hammersmith Hospital, London, UK
Brain 126:312-25. 2003..These findings confirm that striatal dopamine release is a component of movement sequencing and show that dopamine release can be detected in early Parkinson's disease during a behavioural manipulation...
18F-dopa PET evidence that tolcapone acts as a central COMT inhibitor in Parkinson's diseaseRoberto Ceravolo
MRC Cyclotron Unit, Hammersmith Hospital, Institute of Neurology, London, UK
Synapse 43:201-7. 2002..0059 +/- 0.0028) in the absence of this drug. These findings are compatible with clinical doses of tolcapone having a significant blocking effect on peripheral and central COMT but not DDC activity in PD...
Nigrostriatal dysfunction in homozygous and heterozygous parkin gene carriers: an 18F-dopa PET progression studyNicola Pavese
MRC Clinical Science Centre, Imperial College, London, United Kingdom nicola pavese csc mrc ac uk
Mov Disord 24:2260-6. 2009..Although subclinical reductions of striatal (18)F-dopa uptake are common in carriers of a single parkin mutation their slow rate of progression suggests that few if any of these will develop clinical parkinsonism...
Compulsive drug use linked to sensitized ventral striatal dopamine transmissionAndrew H Evans
Reta Lila Weston Institute of Neurological Studies and The National Hospital for Neurology and Neurosurgery, London, United Kingdom
Ann Neurol 59:852-8. 2006..INTERPRETATION: This provides evidence that links sensitization of ventral striatal circuitry in humans to compulsive drug use...
Progression of nigrostriatal dysfunction in a parkin kindred: an [18F]dopa PET and clinical studyNaheed L Khan
MRC Clinical Sciences Centre, and Division of Neuroscience, Faculty of Medicine, Imperial College, Hammersmith Hospital, Du Cane Road, London W12 0NN, UK
Brain 125:2248-56. 2002..However, the two carriers scanned twice showed no progression over a 7-year period. The slower rate of disease progression in parkin patients may explain the near normal longevity of these patients with young onset parkinsonism...
Parkinson disease and impulse control disorders: a review of clinical features, pathophysiology and managementK Wu
Division of Neuroscience and Mental Health, Faculty of Medicine, Imperial College London, Hammersmith Hospital Campus, London, UK
Postgrad Med J 85:590-6. 2009..This review aims to summarise the current literature on ICDs, their phenomenology, epidemiology, clinical features, pathophysiology and management...
Imaging in Parkinson's disease: the role of monoamines in behaviorDavid J Brooks
MRC Clinical Sciences Centre and Division of Neuroscience, Faculty of Medicine, Imperial College London, United Kingdom
Biol Psychiatry 59:908-18. 2006..Novel markers of amyloid plaque load will also help clarify the etiology of dementia in PD...
Neuroprotection and imaging studies in Parkinson's diseaseNicola Pavese
Division of Neurosciences and Mental Health and MRC Clinical Sciences Centre, Faculty of Medicine, Hammersmith Hospital, Imperial College, London, UK
Parkinsonism Relat Disord 15:S33-7. 2009..In this article the value of imaging as a biomarker for testing neuroprotective agents in PD is reviewed...
In vivo assessment of brain monoamine systems in parkin gene carriers: a PET studyNicola Pavese
MRC Clinical Science Centre and Division of Neuroscience and Mental Health, Imperial College, London, UK
Exp Neurol 222:120-4. 2010..These findings suggest that parkin patients and IPD patients with similar striatal dysfunction have different patterns of monoaminergic involvement, with more widespread dysfunction in IPD...
Cortical dopamine dysfunction in symptomatic and premanifest Huntington's disease gene carriersNicola Pavese
MRC Clinical Sciences Centre and Division of Neuroscience, Faculty of Medicine, Imperial College, Hammersmith Hospital, London, UK
Neurobiol Dis 37:356-61. 2010..It is an early event in HD pathophysiology and could contribute to the impairment in neuropsychological performance in these patients...
Cognitive deficits and striato-frontal dopamine release in Parkinson's diseaseNobukatsu Sawamoto
Division of Neuroscience, MRC Clinical Sciences Centre, Imperial College School of Medicine, Hammersmith Hospital, London W12 0NN, UK
Brain 131:1294-302. 2008..In contrast, mesocortical dopaminergic transmission appears well preserved in early PD patients...
Clinical and subclinical dopaminergic dysfunction in PARK6-linked parkinsonism: an 18F-dopa PET studyNaheed L Khan
Department of Molecular Pathogenesis, Institute of Neurology, Imperial College, Hammersmith Hospital, Du Cane Road, London W12 0NN, United Kingdom
Ann Neurol 52:849-53. 2002..The subclinical loss of striatal dopamine storage capacity found in the PARK6 carriers implies that the unidentified gene on the short arm of chromosome 1 exhibits either haploinsufficency or a dominant negative effect...
Imaging microglial activation in Huntington's diseaseYen F Tai
Division of Neuroscience and Psychological Medicine, Hammersmith Hospital, Imperial College London, UK
Brain Res Bull 72:148-51. 2007..Further longitudinal studies are needed to fully elucidate this link...
Two large British kindreds with familial Parkinson's disease: a clinico-pathological and genetic studyD J Nicholl
Department of Neurology, Queen Elizabeth Hospital, Birmingham, UK
Brain 125:44-57. 2002..These kindreds are distinct from other Parkinsonian kindreds with identified genetic loci (PARK1-4) and provide further evidence for genetic heterogeneity in familial Parkinson's disease...
Parkinsonism and nigrostriatal dysfunction are associated with spinocerebellar ataxia type 6 (SCA6)Naheed L Khan
Department of Molecular Neurosciences, Institute of Neurology, London, United Kingdom
Mov Disord 20:1115-9. 2005..We suggest that SCA6, in common with SCA2 and SCA3, may be associated with Parkinsonism attributable to nigral loss and dopaminergic dysfunction. Moreover, isolated cases may be confused with multiple system atrophy...
Applications of positron emission tomography (PET) in neurologyY F Tai
MRC Clinical Sciences Centre and Division of Neuroscience, Faculty of Medicine, Imperial College, Hammersmith Hospital, London, UK
J Neurol Neurosurg Psychiatry 75:669-76. 2004..This article aims to provide an overview of the principles of PET and its applications to clinical neurology...
Positron emission tomography imaging in multiple sclerosis-current status and future applicationsL Kiferle
Centre for Neuroscience and MRC Clinical Sciences Centre, Division of Experimental Medicine, Hammersmith Hospital, Imperial College London, London, UK
Eur J Neurol 18:226-31. 2011..The recent development of new radiolabelled ligands provides positron emission tomography (PET) imaging with a role for studying early aspects of the MS pathology...
Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic dataNaheed L Khan
Department of Molecular Neuroscience, Institute of Neurology, London, UK
Brain 128:2786-96. 2005....
PET image denoising using a synergistic multiresolution analysis of structural (MRI/CT) and functional datasetsFederico E Turkheimer
Department of Clinical Neuroscience, Division of Neuroscience and Mental Health, Imperial College, London, United Kingdom
J Nucl Med 49:657-66. 2008..The method can be naturally extended to other functional imaging modalities (SPECT, functional MRI)...
Cardiovascular effects of methamphetamine in Parkinson's disease patientsNicola Pavese
MRC Clinical Science Center and Division of Neurosciences, Faculty of Medicine, Imperial College. Hammersmith Hospital Campus, London, United Kingdom
Mov Disord 19:298-303. 2004..These findings suggest that in PD there is impairment of catecholamine release from peripheral sympathetic presynaptic terminals, which correlates with motor impairment...
Parkinson's disease symptoms: the patient's perspectiveMarios Politis
Department of Clinical Neurosciences, Faculty of Medicine, Hammersmith Hospital, Imperial College, London, United Kingdom
Mov Disord 25:1646-51. 2010....
Ecstasy (MDMA) does not have long-term effects on aggressive interpretative bias: a study comparing current and ex-ecstasy users with polydrug and drug-naive controlsRosa Hoshi
Clinical Psychopharmacology Unit, University College London, London, United Kingdom
Exp Clin Psychopharmacol 15:351-8. 2007....
Upregulation of dopamine D2 receptors in dopaminergic drug-naive patients with Parkin gene mutationsChristoph Scherfler
MRC Clinical Science Centre and Division of Neuroscience, Faculty of Medicine, Imperial College, Hammersmith Hospital, London, United Kingdom
Mov Disord 21:783-8. 2006..Parkin-positive patients appear to have a greater susceptibility to the exposure to dopaminergic medication than IPD patients, which in turn might be an indirect effect of their genetic mutation...
Striatal and cortical pre- and postsynaptic dopaminergic dysfunction in sporadic parkin-linked parkinsonismChristoph Scherfler
MRC Clinical Science Centre and Division of Neuroscience, Faculty of Medicine, Imperial College, Hammersmith Hospital, Hammersmith Hospital, Du Cane Road, London W12 0NN, UK
Brain 127:1332-42. 2004..Cortical reductions in D2 binding may contribute to the behavioural problems reported in parkin patients...
Plasticity of the nigropallidal pathway in Parkinson's diseaseAlan L Whone
Division of Neuroscience and MRC Clinical Sciences Centre, Faculty of Medicine, Imperial College, Hammersmith Hospital, London, United Kingdom
Ann Neurol 53:206-13. 2003....
